Novo Nordisk A/S
Global week ahead: AI wobble casts shadow over ‘Davos for geeks’
The city of Lisbon in Portugal turns to tech next week, as it plays host to the annual Web Summit conference. The event, also known as the “Davos for geeks,” will feature some of the biggest names in technology at an interesting time for the sector. It attracted more than 70 ,000 attendees last year. […]
Read More
Week in review: The Nasdaq’s worst week since April, three trades, and earnings
It was a terrible start to November on Wall Street. The tech-heavy Nasdaq sank just over 3% in its worst weekly performance since early April. The S & P 500 fell 1.6% for the week. Both stock measures broke three-week winning streaks.This week’s market decline, which followed a strong October, can be chalked up to […]
Read More
Metsera accepts Pfizer’s $10 billion bid in ongoing M&A battle
Smith Collection | Archive Photos | Getty Images Obesity drug developer Metsera said on Friday that it had accepted Pfizer‘s $10 billion acquisition offer, in what could spell the end of a bidding war between the New York-based pharma giant and rival Novo Nordisk that erupted over the last week. Pfizer had appeared to have […]
Read More
Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. 6, 2025. Andrew Caballero-Reynolds | AFP | Getty Images President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in how many people can access […]
Read More
Musk’s $1 trillion pay, a price cut for obesity drugs, Target’s in-store woes and more in Morning Squawk
Tesla CEO Elon Musk attends the Saudi-U.S. Investment Forum, in Riyadh, Saudi Arabia, May 13, 2025. Hamad I Mohammed | Reuters This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Here are five key things investors need to know to start the trading day: 1. +$1 trillion The richest man in […]
Read More
Here’s how much weight loss drugs could cost you under Trump’s deals with Eli Lilly, Novo Nordisk
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk to slash the prices of their blockbuster weight loss drugs. Under the agreements, the monthly out-of-pocket cost of popular injections and […]
Read More
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming […]
Read More
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on Thursday said it will start late-stage trials on its experimental amylin obesity drug next month after it showed encouraging results in a mid-stage study. The highest dose of the weekly injection, called eloralintide, helped patients […]
Read More
CNBC Daily Open: Even a Supreme Court ruling might not spell the end of tariffs
The US Supreme Court in Washington, DC, US, on Monday, Oct. 6, 2025. Graeme Sloan | Bloomberg | Getty Images The U.S. Supreme Court on Wednesday heard a case on the Trump administration’s “reciprocal” tariffs, and both liberal and conservative judges appeared skeptical of the legal basis of those tariffs. Following the hearing, traders on […]
Read More
Healthy Returns: What to know about Pfizer and Novo Nordisk’s bidding war over obesity biotech Metsera
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer and Novo Nordisk are in a takeover clash over the obesity biotech Metsera, with both pharmaceutical giants raising their bids for the startup as of Monday. […]
Read More